API australian pharmaceutical industries limited

sigma

  1. 4,131 Posts.
    Sydney - Monday - December 11: (RWE Aust Business News) -
    Australian Pharmaceutical Industries (ASX:API) has pulled out of
    discussions with Sigma (ASX:SIP) on the takeover proposal, revised at
    $2.20 per API share.
    Chairman Peter Robinson said API was unlikely to agree to terms
    of the current proposal at a price the company had previously rejected
    and it would focus on its plans to restructure and reinvigorate the
    business.
    "The API board has not taken the decision lightly, but after
    taking external advice we unamimously believe the revised all cash price
    of $2.20 undervalues the company," he said.
    He said other discussions were being held with interested parties
    but there is nothing for the board to consider at this stage.
    API shares last traded at $2.33.
    ENDS
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.